Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / GMDA - Gamida Cell surges 22% following rolling BLA submission for omidubicel


GMDA - Gamida Cell surges 22% following rolling BLA submission for omidubicel

Shares of Gamida Cell (GMDA +22.3%) have surged higher after the company today said it started a rolling submission of a Biologics License Application ("BLA") for omidubicel, a treatment for patients with blood cancers in need of stem cell transplant. The company is aiming to complete the submission by Q2. Although he rates Gamida Cell as a hold, Seeking Alpha contributor Bret Jensen says the company has a favorable risk/reward profile.

For further details see:

Gamida Cell surges 22% following rolling BLA submission for omidubicel
Stock Information

Company Name: Gamida Cell Ltd.
Stock Symbol: GMDA
Market: NASDAQ

Menu

GMDA GMDA Quote GMDA Short GMDA News GMDA Articles GMDA Message Board
Get GMDA Alerts

News, Short Squeeze, Breakout and More Instantly...